rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1993-8-24
|
pubmed:abstractText |
The authors previously reported the existence of a unique subtype of peripheral T-cell lymphoma (PTCL) characterized by a clonotypical proliferation of Epstein-Barr virus (EBV) in the tumor cells (Blood 1991; 77:799). Detailed clinicopathologic features of this newly recognized entity remain to be clarified.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
72
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
909-16
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8101471-Adolescent,
pubmed-meshheading:8101471-Adult,
pubmed-meshheading:8101471-Aged,
pubmed-meshheading:8101471-Antibodies, Viral,
pubmed-meshheading:8101471-Carrier Proteins,
pubmed-meshheading:8101471-Child,
pubmed-meshheading:8101471-Child, Preschool,
pubmed-meshheading:8101471-Female,
pubmed-meshheading:8101471-Herpesvirus 4, Human,
pubmed-meshheading:8101471-Histiocytosis, Non-Langerhans-Cell,
pubmed-meshheading:8101471-Humans,
pubmed-meshheading:8101471-Lymphoma, T-Cell, Peripheral,
pubmed-meshheading:8101471-Male,
pubmed-meshheading:8101471-Membrane Glycoproteins,
pubmed-meshheading:8101471-Middle Aged,
pubmed-meshheading:8101471-Neoplasm Proteins,
pubmed-meshheading:8101471-Neoplasm Staging,
pubmed-meshheading:8101471-P-Glycoprotein,
pubmed-meshheading:8101471-Retrospective Studies,
pubmed-meshheading:8101471-Survival Rate,
pubmed-meshheading:8101471-Tumor Virus Infections
|
pubmed:year |
1993
|
pubmed:articleTitle |
Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma.
|
pubmed:affiliation |
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Republic of China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|